Search for: "CEPHALON, INC." Results 81 - 100 of 115
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Apr 2010, 5:52 pm by FDABlog HPM
Cephalon, Inc. –  In this consolidated case concerning Cephalon, Inc.’s PROVIGIL (modafinil) that is pending in the U.S. [read post]
7 Jun 2010, 5:00 am by Michael Kaplen
Clinical research sites across the world are working with biopharmaceutical company Cephalon, Inc., as part of the study to test the effectiveness and safety of an investigational treatment for people with excessive sleepiness caused by a concussion or head injury. [read post]
15 Jan 2009, 6:39 pm
While Zyprexa has been subject of lawsuits, other drug makers such as Cephalon Inc. [read post]
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
25 Sep 2014, 4:30 am by Rob Green
 The named defendants are Jansen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Cephalon. [read post]
28 May 2015, 9:30 pm by RegBlog
Cephalon, Inc. settled with the Federal Trade Commission (FTC) for allegedly reducing competition by preventing the sale of generic versions of the sleep-disorder drug, Provigil. [read post]
22 Oct 2009, 4:23 am
Cephalon, Inc., 2009 WL 3245485 (D.N.J. [read post]
13 Jan 2014, 4:02 am
Take for example, the pharmaceuticals case of Cephalon Inc v Orchid Europe Ltd [2010] EWHC 2945 (Pat) [briefly noted on PatLit here] in which Floyd J (as he was) treated the issue of who is likely to suffer the most irreparable harm as the key factor in the balance of convenience assessment itself: "Balance of convenienceThere is no dispute as to the approach which I should apply. [read post]
30 Nov 2017, 8:59 pm by Brenda Fulmer
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
10 Jul 2013, 12:00 am
 While synthesizing and screening compounds is considered routine experimentation, the Court noted in Cephalon, Inc. v. [read post]
11 Jan 2018, 5:00 am by melissalafreniere
Drug manufacturers and distributors hit with opioid lawsuits include: Purdue Teva/Cephalon Janssen Endo Actavis Mallinckrodt McKesson Corporation AmerisourceBergen Corporation Cardinal Health Inc. [read post]
11 Apr 2016, 2:32 pm by Robert Reznick
  The FTC’s complaint attacks two such settlements that Endo Pharmaceuticals Inc. and the Japan-based patent holder for one of the relevant patents reached with generic manufacturers Watson Laboratories (and Watson’s current owner, Allergan plc) and Impax Laboratories, to settle Hatch-Waxman litigation involving Endo’s two most important products—the pain relievers Opana ER® and Lidoderm®.[2]  The FTC’s complaint, and its simultaneous… [read post]
30 Dec 2009, 6:27 pm by Law Lady
Navagil (Patent Infringement): TEVA FACES LAWSUIT OVER GENERIC VERSION OF SLEEP DISORDER DRUG, Cephalon Inc. v. [read post]
25 Jul 2014, 1:13 pm
Cephalon, Inc., is a third party payor case where plaintiffs – workers compensation insurers – claimed that they were injured by paying for prescriptions for defendant drug company’s  pain medications which were written as a result of its alleged off-label marketing of the drug. [read post]